Article Information
- September 1, 2023.
Article Versions
- Version 1 (July 25, 2020 - 00:57).
- Version 2 (September 2, 2020 - 15:42).
- Version 3 (September 24, 2020 - 15:54).
- Version 4 (October 6, 2020 - 11:18).
- Version 5 (November 23, 2020 - 11:09).
- Version 6 (February 11, 2021 - 14:42).
- Version 7 (April 9, 2021 - 09:07).
- Version 8 (April 11, 2021 - 09:43).
- Version 9 (April 16, 2021 - 08:26).
- Version 10 (July 14, 2021 - 14:26).
- Version 11 (July 28, 2021 - 13:55).
- Version 12 (August 26, 2021 - 11:41).
- Version 13 (September 10, 2021 - 11:03).
- Version 14 (January 5, 2022 - 11:07).
- Version 15 (April 13, 2022 - 08:50).
- You are currently viewing Version 16 of this article (September 1, 2023 - 11:21).
- View Version 17, the most recent version of this article.
REVISION SUMMARY
↵* group members, participating institutions and funders are listed at end of the report
This is the final update of the ISARIC COVID-19 reports. This version has been updated with an additional 144,868 patients recruited between March 2022 and January 2023. All analyses have been updated to reflect the additional patients and phase of the pandemic.
Author Information
- ISARIC Clinical Characterisation Group*,
- J. Kenneth Baillie1,
- Joaquin Baruch2,
- Abigail Beane3,
- Lucille Blumberg4,
- Fernando Augusto Bozza5,
- Tessa Broadley6,
- Aidan Burrell6,
- Gail Carson2,
- Barbara Wanjiru Citarella2,
- Jake Dunning2,
- Loubna Elotmani7,
- Noelia Garcia Barrio8,
- Jean-Christophe Goffard9,
- Matthew Hall2,
- Madiha Hashmi11,
- Peter Horby2,
- Waasila Jassat4,
- Christiana Kartsonaki2,
- Bharath Kumar Tirupakuzhi Vijayaraghavan12,
- Pavan Kumar Vecham13,
- Cedric Laouenan14,
- Samantha Lissauer15,
- Ignacio Martin-Loeches16,
- France Mentre14,
- Ben Morton17,
- Daniel Munblit18,
- Nikita A. Nekliudov18,
- Alistair Nichol19,
- David S.Y. Ong20,
- Prasan Kumar Panda21,
- Miguel Pedrera Jimenez8,
- Michelle Petrovic22,
- Nagarajan Ramakrishnan13,
- Grazielle Viana Ramos5,
- Claire Roger7,
- Amanda Rojek2,
- Oana Sandulescu23,
- Malcolm G. Semple24,
- Pratima Sharma25,
- Sally Shrapnel26,
- Louise Sigfrid2,
- Benedict Sim Lim Heng27,
- Budha Charan Singh21,
- Emily Somers28,
- Anca Streinu-Cercel23,
- Fabio S. Taccone29,
- Jia Wei2,
- Evert-Jan Wils20,
- Xin Ci Wong27,
- Kyle Young26,
- Piero L. Olliaro2 and
- Laura Merson2,^
- 1ISARIC 4C and Roslin Institute, University of Edinburgh, UK
- 2International Severe Acute Respiratory and emerging Infections Consortium (ISARIC), University of Oxford, UK
- 3Critical Care Asia, Thailand
- 4National Institute for Communicable Diseases, South Africa
- 5National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Ministry of Health, and D? Or Institute of Research and Education (IDOR), Brazil
- 6Monash University, Australia
- 7CHU Caremeau, France
- 8Hospital 12 de Octubre, Spain
- 9CUB-Hopital Erasme, Belgium
- 10University of Oxford, UK
- 11Critical Care Asia and Ziauddin University, Pakistan
- 12Critical Care Asia Network, India
- 13Apollo Hospitals Chennai, India
- 14INSERM, France
- 15Malawi-Liverpool Wellcome Trust, Malawi
- 16St James’s Hospital, Ireland
- 17Liverpool School of Tropical Medicine, UK and Malawi-Liverpool Wellcome Trust, Malawi
- 18Sechenov University, Russia
- 19Irish Critical Care Critical Clinical Trials Network, Ireland
- 20Franciscus Gasthuis & Vlietland, The Netherlands
- 21All India Institute of Medical Sciences, India
- 22Humber River Hospital, Canada
- 23National Institute for Infectious Diseases Matei Bals, Romania
- 24ISARIC 4C and University of Liverpool, UK
- 25University of Michigan Schools of Medicine & Public Health, USA
- 26University of Queensland - Saint Lucia Campus: The University of Queensland
- 27National Institutes of Health (NIH), Ministry of Health Malaysia
- 28University of Michigan, USA
- 29CUB-Hopital Erasme, France
- ↵^Correspondence to: Laura.Merson{at}ndm.ox.ac.uk, ISARIC, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK